Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In this pooled analysis of more than 7700 ovarian cancer patients and nearly 12,000 controls, low-dose aspirin and high-dose non-aspirin NSAID use was associated with a risk reduction for invasive epithelial ovarian cancer of 20-34% relative to non-users. Acetaminophen use was not associated with a risk reduction, irrespective of dose or frequency.

'An aspirin a day keeps the ovarian cancer away '